540788
ASPIRA
Start SIP
Invest Now
Start SIP in ASPIRA
Performance
- Low
- ₹62
- High
- ₹68
- 52 Week Low
- ₹50
- 52 Week High
- ₹107
- Open Price₹68
- Previous Close₹63
- Volume762
- 50 DMA₹64.81
- 100 DMA₹64.18
- 200 DMA₹62.76
Investment Returns
- Over 1 Month -1.15%
- Over 3 Month + 4.92%
- Over 6 Month + 21.8%
- Over 1 Year -8%
Smart Investing Starts Here Start SIP with Aspira Pathlab & Diagnostics for Steady Growth!
Aspira Pathlab & Diagnostics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 19.7
- PEG Ratio
- 0
- Market Cap Cr
- 67
- P/B Ratio
- 4.7
- Average True Range
- 4.25
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.18
- RSI
- 44.46
- MFI
- 19.61
Aspira Pathlab & Diagnostics Financials
Aspira Pathlab & Diagnostics Technicals
EMA & SMA
Current Price
₹65.20
+
2.68
(4.29%)
- Bearish Moving Average 1
- Bullish Moving Average 15
- 20 Day
- ₹64.88
- 50 Day
- ₹64.81
- 100 Day
- ₹64.18
- 200 Day
- ₹62.76
Resistance and Support
64.52
- R3 73.65
- R2 71.27
- R1 66.90
- S1 60.15
- S2 57.77
- S3 53.40
Aspira Pathlab & Diagnostics Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-12 | Quarterly Results | |
| 2025-08-12 | Quarterly Results | |
| 2025-05-16 | Audited Results | |
| 2025-02-07 | Quarterly Results | |
| 2024-11-12 | Quarterly Results |
Aspira Pathlab & Diagnostics F&O
About Aspira Pathlab & Diagnostics
- NSE Symbol
- ASPIRA
- BSE Symbol
- 540788
- Managing Director & CEO
- Dr. Pankaj J Shah
- ISIN
- INE500C01017
Similar Stocks to Aspira Pathlab & Diagnostics
Aspira Pathlab & Diagnostics FAQs
Aspira Pathlab & Diagnostics share price is ₹65 As on 09 January, 2026 | 12:39
The Market Cap of Aspira Pathlab & Diagnostics is ₹67.1 Cr As on 09 January, 2026 | 12:39
The P/E ratio of Aspira Pathlab & Diagnostics is 19.7 As on 09 January, 2026 | 12:39
The PB ratio of Aspira Pathlab & Diagnostics is 4.7 As on 09 January, 2026 | 12:39
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.